JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

The Journal of Nuclear Medicine Vol. 35 No. 4 575-579
© 1994 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Henzlova, M. J.
Right arrow Articles by Machac, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Henzlova, M. J.
Right arrow Articles by Machac, J.

Clinical Utility of Technetium-99m-Teboroxime Myocardial Washout Imaging

Milena J. Henzlova and Josef Machac

Division of Nuclear Medicine and Cardiology, Mount Sinai Medical Center, New York, New York

Correspondence: For correspondence contact: M.J. Henzlova, MD, The Mount Sinai Medical Center, Division of Cardiology, One Gustave L. Levy Place, New York, NY 10029.

ABSTRACT

The purpose of this study was to evaluate the clinical utility of 99mTc-teboroxime myocardial washout imaging. The differential washout after a single tracer injection has been proposed as an alternative for characterization of the perfusion defects. Methods: Fifty-six patients received 5-min adenosine infusion. The stress dose of 99mTc-taboroxime was injected at 4.5 min and stress imaging with a single-headed SPECT gamma camera was started at 6 min, washout imaging followed immediately. At 20 min, the rest tracer dose was injected at rest and imaging was started at 21.5 min. The reversibility of the perfusion defects on the washout and rest images was compared visually and quantitatively. Results: There was no statistical difference in the number of stress defects that improved on the washout and rest images. The visual interpretation of the perfusion abnormalities was confirmed by quantitative analysis of relative segmental activity. Conclusion: Thus, 99mTc-teboroxime-adenosine washout myocardial perfusion imaging can be safely and quickly accomplished. Detected reversibility of the perfusion defects did not significantly differ from reversibility observed on the rest images.

Key Words: technetium-99m-teboroxime • washout imaging • adenosine stress






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1994 by the Society of Nuclear Medicine.